Tharimmune, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 9.32 million compared to USD 8.47 million a year ago. Basic loss per share from continuing operations was USD 7.14 compared to USD 18.72 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.328 USD | -16.01% | -9.66% | -35.85% |
04:40pm | Tharimmune to Implement 1-for-15 Reverse Stock Split | MT |
05-09 | Tharimmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.85% | 4.6M | |
+10.43% | 114B | |
+12.96% | 107B | |
-5.49% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.71% | 17.51B | |
-39.36% | 17.17B | |
+7.32% | 14.14B | |
+35.13% | 12.2B |
- Stock Market
- Equities
- THAR Stock
- News Tharimmune, Inc.
- Tharimmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023